Researchers at Karolinska Institutet report that cholesterol metabolites cause specific immune cells in the large intestine to move, which lies behind the formation of the immune system’s important lymphoid tissue in the intestine.

The study, published in the journal Immunity, paves the way for a new possible treatment for patients with inflammatory bowel disease. Tim Willinger, researcher at CIMED and Center for Infectious Medicine, is the leader of the study.
Read the full press release

Kommentera

E-postadressen publiceras inte. Obligatoriska fält är märkta *

You may use these HTML tags and attributes:

<a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>

*